While most studies of immunoediting have focused on T cell mediated immunoediting, a growing number of studies provide evidence highlighting the role that Natural Killer (NK) cells may play, particularly for tumor cells that have lost class I major histocompatibility complex (MHC) cell surface presentation (see below) (20–23). This evidence concerns the gene HLA-C and neoplasm.